HSPA8 and Alzheimer disease: More interestingly, a novel CMA-activating drug, metformin, recently identified during a high-throughput screening, has been found to reduce Aβ protein levels and improve cognitive impairment in a mouse model of AD, via Hsc70 signaling (Xu et al., 2021).